Insulet (PODD) Current Deferred Revenue (2016 - 2019)
Historic Current Deferred Revenue for Insulet (PODD) over the last 11 years, with Q1 2019 value amounting to $1.2 million.
- Insulet's Current Deferred Revenue fell 5745.82% to $1.2 million in Q1 2019 from the same period last year, while for Mar 2019 it was $1.2 million, marking a year-over-year decrease of 5745.82%. This contributed to the annual value of $1.2 million for FY2018, which is 4974.53% down from last year.
- Latest data reveals that Insulet reported Current Deferred Revenue of $1.2 million as of Q1 2019, which was down 5745.82% from $1.2 million recorded in Q4 2018.
- Insulet's Current Deferred Revenue's 5-year high stood at $2.8 million during Q1 2018, with a 5-year trough of $1.1 million in Q1 2017.
- Its 5-year average for Current Deferred Revenue is $1.8 million, with a median of $1.8 million in 2016.
- Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 21045.75% in 2015, then crashed by 5745.82% in 2019.
- Over the past 5 years, Insulet's Current Deferred Revenue (Quarter) stood at $2.4 million in 2015, then plummeted by 44.56% to $1.3 million in 2016, then soared by 79.98% to $2.4 million in 2017, then plummeted by 49.75% to $1.2 million in 2018, then increased by 0.93% to $1.2 million in 2019.
- Its Current Deferred Revenue was $1.2 million in Q1 2019, compared to $1.2 million in Q4 2018 and $2.2 million in Q3 2018.